bay n 7133 has been researched along with Candidiasis, Vulvovaginal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muller, G; Sobel, JD | 1 |
| Nusch, W; Plempel, M | 1 |
2 other study(ies) available for bay n 7133 and Candidiasis, Vulvovaginal
| Article | Year |
|---|---|
Comparison of ketoconazole, Bay N7133, and Bay L9139 in the treatment of experimental vaginal candidiasis.
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Imidazoles; Ketoconazole; Rats; Rats, Inbred Strains; Triazoles | 1983 |
[Microbiological determination of the oral antifungal agent Bay N 7133 and ketoconazole in cervical and vaginal secretion of patients].
Topics: Administration, Oral; Adult; Antifungal Agents; Biological Assay; Candida; Candidiasis, Vulvovaginal; Cervix Mucus; Female; Humans; Ketoconazole; Leukorrhea; Triazoles | 1983 |